No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Cyclophilin D Inhibitor is a type of drug used to treat gastrointestinal diseases. It is a peptidyl-prolyl cis-trans isomerase inhibitor, which works by blocking the activity of the enzyme cyclophilin D. This enzyme is involved in the regulation of inflammation and cell death, and its inhibition can reduce the symptoms of gastrointestinal diseases. Cyclophilin D Inhibitor is used to treat a variety of gastrointestinal diseases, including Crohn's disease, ulcerative colitis, and irritable bowel syndrome. It is also used to treat other conditions such as liver cirrhosis and pancreatitis.
Cyclophilin D Inhibitor is available in both oral and injectable forms. It is generally well tolerated, with few side effects. However, it can cause some gastrointestinal side effects, such as nausea, vomiting, and diarrhea.
Several companies are involved in the Cyclophilin D Inhibitor market, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
